Céline Cano

Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K

Joanne M. Munck, Michael A. Batey, Yan Zhao et al. · Molecular Cancer Therapeutics · 2012 · 131 citations · Full text

Medicine, Oncology, Pharmacology +11

Identification and Characterization of an Irreversible Inhibitor of CDK2

Elizabeth Anscombe, Elisa Meschini, Regina Mora-Vidal et al. · Chemistry & Biology · 2015 · 121 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines

Christopher R. Coxon, Elizabeth Anscombe, Suzannah J. Harnor et al. · Journal of Medicinal Chemistry · 2016 · 119 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

FragLites—Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation

D.J. Wood, J. Daniel Lopez‐Fernandez, Leanne E. Knight et al. · Journal of Medicinal Chemistry · 2019 · 103 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia

Elaine Willmore, Sarah L. Elliott, Tryfonia Mainou‐Fowler et al. · Clinical Cancer Research · 2008 · 91 citations · Full text

Medicine, Molecular Biology, Oncology +17